Related Experiment Video
Updated: Jul 6, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Factitious increases in serum testosterone concentrations related to phenylbutazone therapy
Bernard Uzzan1, Dominique Dumont-Fischer, Najiba Lahlou
1Department of Pharmacology, AP-HP, hôpital Avicenne, 125 route de Stalingrad, 93009-Bobigny, and Paris-XIII University, France. bernard.uzzan@avc.aphp.fr
Abstract:
We report 6 additional observations of a drug/hormone assay interaction between serum testosterone and phenylbutazone intake. This interaction had been described previously only once. We discuss its potential mechanisms, based upon our experimental findings, and its clinical implications.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Testosterone: Functions and Regulation
Hyperthyroidism II: Pathophysiology
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome I: Introduction
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase